__NUXT_JSONP__("/drugs/Apalutamide", (function(a,b,c,d,e){return {data:[{drug:{slug:a,emaEpar:[{activeSubstance:b,conditionIndication:"Erleada is indicated:in adult men for the treatment of non metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.in adult men for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).",inn:b,marketingAuthorisationDate:"2019-01-14 01:00:00",marketingAuthorisationHolder:"Janssen-Cilag International NV",medicineName:c,url:"https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fmedicines\u002Fhuman\u002FEPAR\u002Ferleada"}],fdaDrugLabel:[{brand:"ERLEADA",indication:"1 INDICATIONS AND USAGE ERLEADA is indicated for the treatment of patients with Metastatic castration-sensitive prostate cancer (mCSPC) Non-metastatic castration-resistant prostate cancer (nmCRPC) ERLEADA is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer. ( 1 ) non-metastatic castration-resistant prostate cancer. ( 1 )",manufacturer:"Janssen Products, LP",splSetId:"d1cda4f7-cb33-46ea-b9ac-431f6452b1a5"}],id:a,nciThesaurus:{casRegistry:"956104-40-8",chebiId:d,chemicalFormula:d,definition:"A small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity. Apalutamide binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes. This ultimately inhibits the expression of genes that regulate prostate cancer cell proliferation and may lead to an inhibition of cell growth in AR-expressing tumor cells.",fdaUniiCode:"4T36H88UA7",identifier:"C92574",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C146993"],synonyms:["4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)octan-5-yl)-2-fluoro-N-methylbenzamide","APALUTAMIDE","ARN 509","ARN-509","ARN509",a,c,"JNJ 56021927","JNJ-56021927"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FApalutamide",extension:".json",createdAt:e,updatedAt:e}}],fetch:{},mutations:void 0}}("Apalutamide","apalutamide","Erleada","","2021-10-30T13:47:37.303Z")));